Camille Verry, MD

Centre Hospitalier Universitaire Grenoble Alpes

Disclosures:

Presentations

Sep 28

105 - Use of Gadolinium Nanoparticles as Radiosensitizers for Brain Metastases: Results from the Phase 2 Multicentric Randomized Trial (NANORAD2)
03:20pm - 03:30pm PT